ACHV241220C5000
- 0.05
- 0.000.00%
Achieve Life Newsroom
Oppenheimer Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
Lake Street Sticks to Its Buy Rating for Achieve Life Sciences (ACHV)
Rodman & Renshaw Initiates Achieve Life(ACHV.US) With Buy Rating, Announces Target Price $12
JonesTrading Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $20
Maxim Group Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $10
Achieve Life Sciences: Promising Future With Strategic Leadership and Strong Financial Position Justifies Buy Rating
Lake Street Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
Oppenheimer Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
Oppenheimer Keeps Their Buy Rating on Achieve Life Sciences (ACHV)
Lake Street Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
JonesTrading Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $20
Lake Street Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
Lake Street Keeps Their Buy Rating on Achieve Life Sciences (ACHV)
Achieve Life Sciences Initiated With a Strong Buy at Raymond James
Raymond James Initiates Achieve Life(ACHV.US) With Buy Rating, Announces Target Price $20
Achieve Life Sciences Initiated With a Strong Buy at Raymond James
Lake Street Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
JonesTrading Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $20
Buy Rating for Achieve Life Sciences: Strategic Growth and Solid Financials Amidst Leadership Transition
Oppenheimer Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11